Federal opioid package receives bipartisan support in the U.S. House On June 22, the U.S. House of Representatives passed HR 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. It includes more than 55 opioid-related bills intended to help combat the nation’s opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting our communities and bolstering our efforts to fight deadly illicit synthetic drugs. HR 6 also includes several Medicaid, Medicare and public health reforms to help combat the opioid crisis. The California Medical Association (CMA) aggressively advocated for more funding ... July 11, 2018 General Prescription Drugs, Drug Prescribing, Federal Legislative Advocacy 0 0 Comment Read More »
Saturday, April 28, is National Prescription Drug Take Back Day Saturday, April 28, 2018, is National Prescription Drug Take Back Day. On this day, hundreds of locations throughout California will be accepting and properly disposing of unused prescription drugs, including controlled substances. Proper disposal of unused prescription drugs helps prevent diversion and misuse associated with these medications. This one-day event will provide patients with free, anonymous collection of unwanted and expired medicines. The last National Take Back event collected 456 tons of unwanted prescription drugs at almost 5,500 collection sites nationwide. In addition to providing a safe, convenient and responsible means ... April 17, 2018 General Prescription Drugs 0 0 Comment Read More »
Are your prescription pads compliant with the law? The California Medical Association (CMA) has received numerous calls from physicians whose prescriptions are being turned away by pharmacies for being non-compliant with state law. Specifically, the forms in question do not have checkboxes to indicate refills. California law requires 14 elements that must appear on California security prescription forms, including "check boxes that shall be printed on the form so that the prescriber may indicate the number of refills ordered." Security forms that lack the check boxes, even if they indicate refills in a different way, are deemed non-compliant. ... December 28, 2017 General Drug Prescribing, Prescription Drugs 0 0 Comment Read More »
Saturday, Oct. 28, is National Prescription Drug Take Back Day Saturday, October 28, 2017, is National Prescription Drug Take Back Day. On this day, hundreds of locations throughout California will be accepting and properly disposing of unused prescription drugs, including controlled substances. Proper disposal of unused prescription drugs helps prevent diversion and misuse associated with these medications. This one-day event will provide patients with free, anonymous collection of unwanted and expired medicines. The last National Take Back event collected 450 tons of unwanted prescription drugs at almost 9,700 collection sites nationwide. In addition to providing a safe, convenient and responsible means ... October 19, 2017 General Opioids, Prescription Drugs 0 0 Comment Read More »
Updates to prior authorization form for prescription medications and new timelines for response now in effect On July 1, 2017, two new laws affecting the standardized prescription drug prior authorization form took effect. SB 282 required the Department of Managed Health Care (DMHC) and the Department of Insurance to create a standard electronic prior authorization request form. A second related law (AB 374) required the agencies to include on the updated form the option for physicians to request an exception to the plan/insurer’s step therapy process. Previously, SB 866 had required use and acceptance of a paper uniform prior authorization form. The form was updated in December ... September 25, 2017 General Drug Prescribing, Preauthorization, Prescription Drugs 0 0 Comment Read More »
CSAM Webinar: How to Build a Controlled-Substances Review Committee in Your Primary Care Clinic The California Society of Addiction Medicine (CSAM) is hosting a webinar, "How to Build a Controlled-Substances Review Committee in Your Primary Care Clinic," to help physicians navigate chronic pain and opioid management. The webinar will take place on Friday, July 28, from 12-1 p.m. Using a case-based format, the webinar will review the basic structure, operations and benefits of creating an internal peer-review committee for complex pain cases. From this event, physicians will understand how to implement, how to interact with and when to use such a committee in their ... July 26, 2017 General Continuing Medical Education, Drug Prescribing, Prescription Drugs, Webinars 0 0 Comment Read More »
NASEM issues major report on pain management and opioid use The National Academies of Science, Engineering, and Medicine (NASEM) issued a report last week, "Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use," detailing the dual public health challenges of undertreated pain and opioid use disorder. The report, requested by the U.S. Food and Drug Administration (FDA), highlights actions health care professionals and government agencies could take to stem the prevalence of opioid misuse without denying access to opioids for patients suffering from pain. The 18-member committee that worked over a year ... July 24, 2017 General Drug Prescribing Opioids, Opioids, Pain Medicine, Prescription Drugs 0 0 Comment Read More »
FDA wants opioid pulled from market due to risk of abuse Last week, the U.S. Food and Drug Administration (FDA) requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is concerned that the benefits of the drug may no longer outweigh its risks. This is the first time the FDA has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse. The FDA’s decision is based on a review of all available data and follows a March 2017 ... June 21, 2017 General Food and Drug Administration, Prescription Drugs, Drug Abuse, Opioids 0 0 Comment Read More »
Pharmacy board announces rules for pharmacy drug take-back services The California State Board of Pharmacy has finalized rules for pharmacy prescription drug take-back programs. The proposed regulations are part of statewide efforts to combat prescription drug misuse by making it easier for patients to safely dispose of old and unwanted drugs. A significant component of the prescription drug abuse and diversion problem stems from misuse of unused drugs. According to the Substance Abuse and Mental Health Administration, over 71 percent of prescription pain medications are obtained from family and friends, and 5 percent took the medication from a friend ... June 21, 2017 General Prescription Drugs 0 0 Comment Read More »
DHCS gets federal grant to increase access to opioid treatment in California The California Department of Health Care Services (DHCS) has received a $90 million grant from the federal government to expand drug treatment services in California, primarily in counties and tribal communities that have higher rates of opioid-related overdose deaths. One key initiative will target those areas with an innovative approach to increase access to medications used to treat opioid addiction. DHCS will use a large portion of the grant from the U.S. Substance Abuse and Mental Health Services Administration to expand Californians’ access to medication-assisted treatment for opioid use disorders, ... May 22, 2017 General Drug Abuse, Medical Solutions to Drug Abuse, Opioids, Prescription Drugs 0 0 Comment Read More »
